NAUT

Nautilus Biotechnology
$1.66
−$0.03 (−1.78%)Jul 27, 2026
3.0FairMoatMint rating

MoatMint rates Nautilus Biotechnology (NAUT) 3.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.7 out of 10.

Key metrics

The numbers that frame NAUT today
Market cap
$210.95M
P/E (TTM)
-3.7
EV / FCF
-4.4
ROIC
-29.3%
Div yield
0%
Debt / equity
0.2
52wk Low
$0.62
52wk High
$4.31

NAUT stock rating

How NAUT scores on quality, value, growth, momentum and financial health
3.0out of 10
Fair overallFair business, expensive priceTop 70% of ~5,000 US stocks
QualityFair2.7/10
GrowthFair2.1/10
MomentumGreat9.1/10
ValuePoor1.5/10
Financial HealthFair2.4/10

Growth

Revenue and earnings trend for NAUT
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NAUT
Is Nautilus Biotechnology a good buy?
Hold. Nautilus Biotechnology has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Nautilus Biotechnology is selling at a very high price.
What is the market capitalization of NAUT?
Nautilus Biotechnology's market capitalization is $210.95M.
What is the P/E ratio for NAUT stock?
Nautilus Biotechnology's current P/E ratio is -3.7.
What is the 52-week high for NAUT stock?
The 52-week high for Nautilus Biotechnology is $4.31. The current close of $1.66 is 61.5% below that high.
What is the 52-week low for NAUT stock?
The 52-week low for Nautilus Biotechnology is $0.62. The current close of $1.66 is 167.7% above that low.
Does NAUT stock pay dividends?
Nautilus Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NAUT?
Nautilus Biotechnology's Debt / Equity ratio is 0.2.